Brief: Somnomed Reaffirms FY22 Forecast

SomnoMed

27/04/2022 02:10

April 27 (Reuters) - Somnomed Ltd  SOM.AX :
    * FY22 GUIDANCE REAFFIRMED
    * REVENUE OF A$17.3 MILLION FOR Q3 FY22, UP 10% PCP
    * REMAINS OPTIMISTIC ABOUT TRADING ACTIVITY LEVELS AND
OUTLOOK FOR
FY22

Source text for Eikon:  ID:nASX9CJdJp 
Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))